Aspira Women’s Health Inc. Proceeds from Lines of Credit
Aspira Women’s Health Inc. (AWHL) reported Proceeds from Lines of Credit of $7.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2026-05-15
- Aspira Women’s Health Inc. proceeds from lines of credit for the quarter ending 2026-03-31 was $7.00K.
- Aspira Women’s Health Inc. proceeds from lines of credit for the quarter ending 2025-09-30 was $0.00.
- Aspira Women’s Health Inc. proceeds from lines of credit for the quarter ending 2023-12-31 was $999.00K.
- Aspira Women’s Health Inc. proceeds from lines of credit for the quarter ending 2023-09-30 was $9.00K.
- Aspira Women’s Health Inc. proceeds from lines of credit for fiscal 2023 was $1.18M.
- Aspira Women’s Health Inc. proceeds from lines of credit for fiscal 2020 was $2.00M.
- Aspira Women’s Health Inc. proceeds from lines of credit for fiscal 2016 was $1.97M.
| Period end | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-15 | |||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $25.00K 10-Q · filed 2025-11-14 | ||
| 2025-06-30 | $25.00K 10-Q · filed 2025-08-13 | |||
| 2023-12-31 | $999.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $1.01M derived: sum of 2 quarters · filed 2024-04-01 | $1.18M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $178.00K 10-Q · filed 2023-11-13 | ||
| 2023-06-30 | $169.00K 10-Q · filed 2023-08-14 | |||
| 2020-12-31 | $2.00M 10-K · filed 2022-03-31 | |||
| 2016-12-31 | $1.97M 10-K · filed 2018-03-13 |